Medicare Enrolled

Dr. Barakat Thabet, MD

Rheumatology · Grand Rapids, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3271 CLEAR VISTA CT NE, Grand Rapids, MI 49525
6162677293
In practice since 2012 (13 years)
NPI: 1184979577 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Thabet from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thabet? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Thabet

Dr. Barakat Thabet is a rheumatology specialist in Grand Rapids, MI, with 13 years of NPI registration. Based on federal Medicare data, Dr. Thabet performed 383 Medicare services across 278 unique beneficiaries.

Between the years covered by Open Payments, Dr. Thabet received a total of $107,803 from 29 pharmaceutical and/or device companies across 816 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Thabet is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ 383 Medicare services $107,803 industry payments

Medicare Practice Summary

Medicare Utilization ↗
383
Medicare services
Bottom 39% in MI for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
278
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
234 $80 $221
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
42 $111 $344
Injection, methylprednisolone acetate, 40 mg 33 $5 $11
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
28 $47 $264
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
25 $10 $65
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
21 $8 $16
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$107,803
Total received (2018-2024)
Avg $15,400/year across 7 years
Top 6% in MI for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
816
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$92,320 (85.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,794 (8.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,690 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,583
2023
$14,898
2022
$35,871
2021
$24,198
2020
$10,320
2019
$12,589
2018
$345

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$6,675
Amgen Inc.
$950
AstraZeneca Pharmaceuticals LP
$437
Janssen Biotech, Inc.
$288
Novartis Pharmaceuticals Corporation
$210
Alexion Pharmaceuticals, Inc.
$163
PFIZER INC.
$132
Lilly USA, LLC
$121
Organon Llc
$104
UCB, Inc.
$104
Kiniksa Pharmaceuticals International, plc
$91
E.R. Squibb & Sons, L.L.C.
$85
Fresenius Kabi USA, LLC
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Radius Health, Inc.
$39
Actelion Pharmaceuticals US, Inc.
$25
SOBI, INC
$19
Sandoz Inc.
$19
Genentech USA, Inc.
$18
DePuy Synthes Sales Inc.
$14
Top 3 companies account for 84.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$33,648
ABBVIE INC.
$31,202
AbbVie Inc.
$22,048
AbbVie, Inc.
$12,055
Janssen Biotech, Inc.
$2,455
Amgen Inc.
$2,369
AstraZeneca Pharmaceuticals LP
$933
Novartis Pharmaceuticals Corporation
$642
PFIZER INC.
$481
Alexion Pharmaceuticals, Inc.
$288
Lilly USA, LLC
$276
UCB, Inc.
$188
Aurinia Pharma U.S., Inc.
$162
Fresenius Kabi USA, LLC
$139
Stryker Corporation
$134
E.R. Squibb & Sons, L.L.C.
$123
Boehringer Ingelheim Pharmaceuticals, Inc.
$121
Organon Llc
$104
Actelion Pharmaceuticals US, Inc.
$93
Kiniksa Pharmaceuticals International, plc
$91
Genentech USA, Inc.
$68
Radius Health, Inc.
$39
SOBI, INC
$39
Kiniksa Pharmaceuticals, Ltd.
$21
kaleo, Inc.
$20
Sandoz Inc.
$19
Alvogen Inc
$18
Janssen Pharmaceuticals, Inc
$14
DePuy Synthes Sales Inc.
$14
Top 3 companies account for 80.6% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · AUVI-Q · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · XELJANZ · XPRESS ENT DILATION SYSTEM
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for rheumatology in MI.

Looking for a rheumatology specialist in Grand Rapids?
Compare rheumatologists in the Grand Rapids area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
14
Per 100K population
2.1
County median income
$80,390
Nearest hospital
SPECTRUM HEALTH
5.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Thabet is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of MI peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Thabet experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Thabet performed 234 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Thabet receive payments from pharmaceutical companies?
Yes. Dr. Thabet received a total of $107,803 from 29 companies across 816 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thabet's costs compare to other rheumatologists in Grand Rapids?
Dr. Thabet's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Thabet) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →